Nemeh, C., Schmoke, N., Patten, W., Clark, E., Wu, Y. S., Wang, P., Kurlansky, P., Middlesworth, W., Cheung, E. W., & Rosenzweig, E. B. (2024). Extracorporeal membrane oxygenation (ECMO) support for children with pulmonary hypertension: A single‐institutional experience of outcomes. Pulmonary Circulation, 14(4). Portico. https://doi.org/10.1002/pul2.12442

Vohra, A. S., Olonoff, D. A., Ip, A., Kirtane, A. J., Steinberg, Z., Horn, E., Krishnan, U., Reisman, M., Bergman, G., Wong, S., Feldman, D. N., Kim, L. K., & Singh, H. S. (2024). Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012–2019). Pulmonary Circulation, 14(2). Portico. https://doi.org/10.1002/pul2.12374

Avitabile, C. M., Krishnan, U. S., Yung, D., Handler, S. S., Varghese, N., Bates, A., Fineman, J., Sullivan, R., Friere, G., Austin, E., Mullen, M. P., Pereira, C., Christensen, E. J., Yenokyan, G., Collaco, J. M., Abman, S. H., Romer, L., Dunbar Ivy, D., & Rosenzweig, E. B. (2024). Actigraphy methodology in the Kids Mod PAH trial: Physical activity as a functional endpoint in pediatric clinical trials. Pulmonary Circulation, 14(1). Portico. https://doi.org/10.1002/pul2.12339

Khangoora, V., Bernstein, E. J., King, C. S., & Shlobin, O. A. (2023). Connective tissue disease‐associated pulmonary hypertension: A comprehensive review. Pulmonary Circulation, 13(4). Portico. https://doi.org/10.1002/pul2.12276

Collaco, J. M., Abman, S. H., Austin, E. D., Avitabile, C. M., Bates, A., Fineman, J. R., Freire, G. A., Handler, S. S., Ivy, D. D., Krishnan, U. S., Mullen, M. P., Varghese, N. P., Yung, D., Nies, M. K., Everett, A. D., Zimmerman, K. O., Simmons, W., Chakraborty, H., Yenokyan, G., … Romer, L. H. (2023). Kids Mod PAH trial: A multicenter trial comparing mono‐ versus duo‐therapy for initial treatment of pediatric pulmonary hypertension. Pulmonary Circulation, 13(4). Portico. https://doi.org/10.1002/pul2.12305

Naranjo, M., Rosenzweig, E. B., Hemnes, A. R., Jacob, M., Desai, A., Hill, N. S., Larive, A. B., Finet, J. E., Leopold, J., Horn, E., Frantz, R., Rischard, F., Erzurum, S., Beck, G., Mathai, S. C., & Hassoun, P. M. (2023). Frequency of acute vasodilator response (AVR) in incident and prevalent patients with pulmonary arterial hypertension: Results from the pulmonary vascular disease phenomics study. Pulmonary Circulation, 13(3). Portico. https://doi.org/10.1002/pul2.12281

Frantz, R. P., Leopold, J. A., Hassoun, P. M., Hemnes, A. R., Horn, E. M., Mathai, S. C., Rischard, F. P., Larive, A. B., Tang, W. h. W., Park, M. M., Hill, N. S., & Rosenzweig, E. B. (2023). Acute vasoreactivity testing during right heart catheterization in chronic thromboembolic pulmonary hypertension: Results from the pulmonary vascular disease phenomics study. Pulmonary Circulation, 13(1). Portico. https://doi.org/10.1002/pul2.12181

Grinnan, D., Kang, L., DeWilde, C., Badesch, D., Benza, R., Bull, T., Chakinala, M., DeMarco, T., Feldman, J., Ford, H. J., Klinger, J., McConnell, J., Rosenzweig, E. B., Sager, J., Shlobin, O., & Zamanian, R. (2022). Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluation. Pulmonary Circulation, 12(3). Portico. https://doi.org/10.1002/pul2.12120

Handler, S. S., Varghese, N. P., Rosenzweig, E. B., Yung, D., Krishnan, U., Whalen, E., Bates, A., Avitabile, C. M., Jackson, E. O., Hirsch, R., Fineman, J., & Abman, S. H. (2022). Building a dedicated pediatric pulmonary hypertension program: A consensus statement from the pediatric pulmonary hypertension network. Pulmonary Circulation, 12(1). Portico. https://doi.org/10.1002/pul2.12031

Stevens, L., Colglazier, E., Parker, C., Amin, E. K., Nawaytou, H., Teitel, D., Reddy, V. M., Welch, C. L., Chung, W. K., & Fineman, J. R. (2022). Genetics dictating therapeutic decisions in pediatric pulmonary hypertension? A case report suggesting we are getting closer. Pulmonary Circulation, 12(1). Portico. https://doi.org/10.1002/pul2.12033

Yang, J., Ambade, A. S., Nies, M., Griffiths, M., Damico, R., Vaidya, D., Brandal, S., Pauciulo, M. W., Lutz, K. A., Coleman, A. W., Nichols, W. C., Austin, E. D., Ivy, D., Hassoun, P. M., & Everett, A. D. (2022). Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival. Pulmonary Circulation, 12(1). Portico. https://doi.org/10.1002/pul2.12007